The researchers identified 131 fecal and mucosal samples from 14 recurrent Clostridium difficile infection patients, both before and after the patients had received fecal microbiota transplantation. They analyzed the microbiota profiles from these patients at their one-year follow-up, to determine whether the restored intestinal microbiota and suppressed C. difficile bacteria seen in the short-term were sustained.
Here’s what you need to know:
1. At the one-year mark, the fecal microbiota transplantation treatment was still successful in all patients.
2. The patients’ gut microbiomes were dominated by Clostridium clusters IV and XIVa, which are major anaerobic bacterial groups seen in healthy patients.
3. In the mucosa, the amount of Bacteroidetes bacteria stabilized, as well.
More articles on gastroenterology and endoscopy:
Pharmacy costs exceed inpatient, outpatient care costs for Crohn’s patients: 5 study insights
NYU Langone names Dr. Feza Remzi director of the IBD center: 3 notes
What CRC screening method boasts the best long-term compliance? 3 study insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
